Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Trevi Therapeutics, Inc. (TRVI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2023 |
4
| Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 682 shares
@ $2.36, valued at
$1.6k
Exercised 2,292 options to buy
@ $0.511, valued at
$1.2k
|
|
| 07/12/2023 |
4
| Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 687 shares
@ $2.34, valued at
$1.6k
Exercised 2,292 options to buy
@ $0.511, valued at
$1.2k
|
|
| 06/30/2023 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| Cassella James V (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| Meeker David P (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| Colangelo Dominick (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/30/2023 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 03/15/2023 |
4
| Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 892 shares
@ $1.7532, valued at
$1.6k
Exercised 2,291 options to buy
@ $0.511, valued at
$1.2k
|
|
| 03/08/2023 |
4
| Simon Farrell (Chief Commercial Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Exercised 18,750 options to buy
@ $0.511, valued at
$9.6k
|
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| SCIASCIA THOMAS (Chief Medical Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $3.21, valued at
$24.1k
|
|
| 09/19/2022 |
4
| GOOD JENNIFER L (President & CEO) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $3.21, valued at
$102.7k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.27, valued at
$45.4k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Colangelo Dominick (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.27, valued at
$45.4k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| TPG GP A, LLC (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 600 shares
@ $2.7, valued at
$1.6k
|
|
| 05/02/2022 |
4
| TPG GP A, LLC (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Sold 7,271 shares
@ $2.7699, valued at
$20.1k
Sold 16,163 shares
@ $2.7461, valued at
$44.4k
|
|
| 04/13/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 948,948 shares
@ $1.9, valued at
$1.8M
Granted 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
| 04/13/2022 |
4
| Walker Paul Edward (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 2,631,578 shares
@ $1.9, valued at
$5M
Bought 948,948 shares
@ $1.9, valued at
$1.8M
Bought 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
| 04/13/2022 |
4
| Sonsini Peter W. (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 2,631,578 shares
@ $1.9, valued at
$5M
Bought 948,948 shares
@ $1.9, valued at
$1.8M
Bought 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
| 04/13/2022 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 2,631,578 shares
@ $1.9, valued at
$5M
Bought 948,948 shares
@ $1.9, valued at
$1.8M
Bought 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
| 04/13/2022 |
4
| Makhzoumi Mohamad (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 2,631,578 shares
@ $1.9, valued at
$5M
Bought 948,948 shares
@ $1.9, valued at
$1.8M
Bought 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
| 04/13/2022 |
4
| Florence Anthony A. Jr. (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 2,631,578 shares
@ $1.9, valued at
$5M
Bought 948,948 shares
@ $1.9, valued at
$1.8M
Bought 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
| 04/13/2022 |
4
| Chang Carmen (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Bought 2,631,578 shares
@ $1.9, valued at
$5M
Bought 948,948 shares
@ $1.9, valued at
$1.8M
Bought 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
|
|
|